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The UK and its anxious neighbours
are currently focusing on foot and
mouth disease but agricultural
researchers are still working on a
much deeper and worrying problem:
BSE and its human form, new variant
CJD. Unlike foot and mouth disease,
much remains unknown about the
aberrant prion protein agent of BSE
and how it causes disease. One of the
biggest stumbling blocks to research
is the lack of a relatively simple and
reliable test to show early infection
with the agent. But researchers now
reporting in Nature Medicine (March
2001) provide the first hint that this
mysterious disease may leave a
molecular footprint during the early
stages of infection that could provide
a new means of testing for the
disease.
Michael Clinton and a colleague
at the Roslin Institute near
Edinburgh, Scotland and another
colleague at the Institute for Animal
Health in Edinburgh have looked in
detail at the expression of messenger
RNA molecules in cells from control,
healthy mice and compared them
with cells from mice infected by the
BSE agent. The aim was to see if
there might be any early indication of
infection outside of the brain where
classical signs of the late-stage
disease are found. When they looked
at spleen cells from the mice,
although the level of many thousands
of different transcripts in normal and
infected mice were comparable, the
team found that one transcript was
found at a significantly lower in the
spleen cells of infected mice.
Study of the sequence of this
transcript revealed that it was similar
to one designated as erythroid
differentiation-related factor (EDRF)
named because of its previous
isolation from mouse erythroblasts
and human bone marrow. The team
also found that different strains of
transmissible spongiform
encephalopathy (TSE) in both mice
and hamsters led to a similar drop in
the level of expression of the EDRF-
encoding mRNA.
Any test that can detect infection
earlier from samples taken from
live animals would represent a
major step forward
The team then went on to look at
samples of material taken from cattle
known to be infected with BSE and
sheep with scrapie. Compared with
normal controls, expression of EDRF
was considerably decreased in bone
marrow of cattle displaying initial
clinical signs of BSE and in the blood
of sheep showing clinical signs of
scrapie.
The team do not yet know how
the observed changes in EDRF
activity relate to infection. The effect
may be indirect rather than direct.
Nor is it clear at this stage precisely
how good a diagnostic marker EDRF
may be for detecting early stages of
the disease. But what is clear is that
this appears to be the first
demonstration of a TSE-induced
effect on gene activity outside the
central nervous system and that
opens up new avenues of research
both for diagnosis and for
understanding more about the
progress of infection.
James Moynah, a member of the
the European Commission’s health
and consumer protection directorate-
general, which coordinates some of
the European Union’s (EU) policy on
BSE and other related diseases,
believes the new work is of great
potential interest. Britain, where
BSE was first recognised, has led the
way on TSE research spending
£140 million on the subject since
TSE was first identified in the 1980s.
But as the disease in cattle and
humans has now started to appear in
other European countries the EU has
taken a growing role in coordinating
research efforts. The EU has so far
authorised the use of three different
tests to detect BSE infection in
animals. “The problem is that they
all rely on the detection of the
abnormal prion protein in brain tissue
of animals so can only be done post-
mortem,” he says. “Any test that can
detect infection earlier from samples
taken from live animals would
represent a major step forward,” he
says.
Efforts are now also under way to
provide researchers with better
material for work on diagnostic tests.
“We have set up an experiment for
the infection of cattle so that
researchers can have access to
material at known times following
infection,” a spokesperson for
Britain’s ministry of agriculture said.
But in an ironic twist, Britain’s
current foot and mouth disease crisis
is having its knock-on effect on BSE
research. “Samples of material are
now subject to movement
restrictions, similar to the animals
themselves,’’ says Moynah. “The
proposed schedule for research and
testing is now having to slip.”
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